MAIA logo

MAIA Biotechnology, Inc.


MAIA: MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.


Show MAIA Financials

Consumer Interest
SEC Filings

Recent trades of MAIA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by MAIA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of MAIA in WallStreetBets Daily Discussion


Recent insights relating to MAIA

CNBC Recommendations

Recent picks made for MAIA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MAIA

Corporate Flights

Flights by private jets registered to MAIA